Immatics (IMTX) Research & Development (2019 - 2026)

Immatics has reported Research & Development for 7 years, with the latest figure at -$57.8 million in Q4 2025.

• Quarterly Research & Development fell 29.22% year-over-year to -$57.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$208.1 million (down 29.84% YoY) and the FY2025 annual result came in at -$207.7 million, down 29.59% from the prior year.
• Research & Development fell to -$57.8 million in Q4 2025 per IMTX's latest filing, from -$55.2 million in the prior quarter.
• Over five years, Research & Development peaked at -$24.5 million in Q2 2021 and troughed at -$57.8 million in Q4 2025.
• A 5-year average of -$35.6 million and a median of -$31.5 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2021 and 2022: Research & Development sank 105.66% in 2021, then fell 1.5% in 2022.
• Over 5 years, Research & Development stood at -$26.3 million in 2021, then fell by 8.16% to -$28.4 million in 2022, then dropped by 25.99% to -$35.8 million in 2023, then decreased by 24.94% to -$44.7 million in 2024, then fell by 29.22% to -$57.8 million in 2025.
• According to Business Quant data, Research & Development over the past three periods registered -$57.8 million, -$55.2 million, and -$51.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.